Insights
Research, product thinking, and strategy notes for founders building in healthcare, AI, and technically demanding sectors.
May 19, 2025 • LotusChain R&D
Explore how AI and machine learning are transforming breast cancer diagnostics, improving early detection, and personalizing treatment plans.
Read articleMay 19, 2025 • LotusChain R&D
Understand the evolving regulatory environment for AI-based diagnostic tools in oncology and how startups can navigate these challenges.
Read articleMay 19, 2025 • LotusChain R&D
Discover the latest funding trends and investment opportunities in AI-driven healthcare startups, with a focus on breast cancer diagnostics.
Read articleMay 19, 2025 • LotusChain R&D
Examine the ethical considerations and potential challenges of integrating AI into breast cancer diagnostics, and how startups can address these issues.
Read articleMay 19, 2025 • LotusChain R&D
Learn about the future opportunities and strategic insights for startups venturing into AI-driven breast cancer diagnostics.
Read articleApril 15, 2025 • LotusChain R&D
A comprehensive guide for healthcare startups to understand and successfully navigate the complex regulatory landscape while maintaining innovation velocity.
Read articleApril 8, 2025 • LotusChain R&D
Strategies for founders to build, manage, and scale high-performing remote teams while maintaining strong culture and operational excellence.
Read articleApril 1, 2025 • LotusChain R&D
Exploring how autonomous AI agents are creating new market opportunities and how startups can position themselves to capitalize on this emerging technology trend.
Read articleSeptember 3, 2026 • LotusChain R&D
UCLA’s newly published SLIViT framework reaches specialist-level accuracy on complex 3D scans while using far less labeled data and running thousands of times faster. We break down the technical advance and what it means for diagnostic startups.
Read articleAugust 28, 2026 • LotusChain R&D
From Mayo Clinic’s MedEduChat and Enhanced Triage Agent to Google’s AMIE and new enterprise platforms from Amazon, Oracle, and Epic, agentic systems are beginning to handle multi-step clinical and administrative tasks. Here’s what the data shows and how startups should position themselves.
Read articleAugust 25, 2026 • LotusChain R&D
In August 2026 the FDA issued a discussion paper on regulating generative-AI-enabled medical devices and invited public comment through October 19. The proposed competency-based framework and post-market emphasis will reshape how healthcare AI startups design, validate, and iterate their products.
Read article
September 6, 2026 • LotusChain R&D
AlPa is a secure, portable, vendor-neutral AI inference platform built on WebAssembly + WebGPU with Dawn as the native backend — one codebase that runs in browsers, edge devices, servers, and embedded systems.
Read articleSeptember 8, 2026 • LotusChain R&D
Inside AlPa's runtime security model: license validation before every model load and inference call, background heartbeat re-validation, and Ed25519-signed offline licenses for air-gapped deployments.
Read articleSeptember 7, 2026 • LotusChain R&D
DiagFlow executes supported vision models locally inside the browser via WebGPU/WebAssembly and ONNX Runtime Web — cutting cloud hosting costs from $1,680 to $55 per 10,000 scans while improving privacy by design.
Read articleSeptember 9, 2026 • LotusChain R&D
DiagFlow pairs immutable, auditable pipeline graphs with a Workflow Marketplace where medical creators keep 90% of subscription revenue — governance builds trust, and the marketplace compounds it.
Read article
September 9, 2026 • LotusChain R&D
Lotus Health, LOTUS CHAIN Hub's healthcare AI initiative, pairs imaging-focused AI with supporting reasoning systems to surface suspicious findings, guide review, and improve clinical workflow efficiency in breast cancer detection.
Read articleSeptember 9, 2026 • LotusChain R&D
Structured outputs, guided review, and workflow-ready clinical insight — how Lotus Health turns breast cancer imaging analysis into decision support that professionals can actually act on.
Read article